Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 May;33(5):512–520. doi: 10.1038/bjc.1976.82

Trapping and destruction of blood-borne syngeneic leukaemia cells in lung, liver and spleen of normal and leukaemic rats.

T E Sadler, P Alexander
PMCID: PMC2024958  PMID: 1064431

Abstract

Leukaemic cells from rats with a lymphoid (HRL) or myeloid (SAL) leukaemia were labelled with 125IUDR and injected i.v. into either normal or leukaemic syngeneic recipients. The fate of the injected cells was studied in terms of the radioactivity in various tissues at various times up to 24 h later. In normal animals the leukaemia cells were destroyed rapidly in the reticulo-endothelial (RE) system; immediately after injection most recoverable activity was in the lung, with smaller amounts in the blood, spleen and liver but by 24 h only 20-30% of the injected activity could be recovered. In leukaemic recipients with high numbers of blasts in the blood the amount of activity recoverable from the lungs and bone-marrow was markedly reduced, while that in the blood was doubled. Nonetheless, the overall rate at which radioactivity was eliminated was not significantly different from that found in normal rats, in spite of the fact that the RE system was extensively infiltrated by leukaemia cells.

Full text

PDF
512

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander P., Evans R. Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol. 1971 Jul 21;232(29):76–78. doi: 10.1038/newbio232076a0. [DOI] [PubMed] [Google Scholar]
  2. Commerford S. L. Biological stability of 5-iodo-2'-deoxyuridine labelled with iodine-125 after its incorporation into the deoxyribonucleic acid of the mouse. Nature. 1965 May 29;206(987):949–950. doi: 10.1038/206949a0. [DOI] [PubMed] [Google Scholar]
  3. Fidler I. J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer. 1973 Mar;9(3):223–227. doi: 10.1016/s0014-2964(73)80022-2. [DOI] [PubMed] [Google Scholar]
  4. HUGHES W. L., COMMERFORD S. L., GITLIN D., KRUEGER R. C., SCHULTZE B., SHAH V., REILLY P. DEOXYRIBONUCLEIC ACID METABOLISM IN VIVO: I. CELL PROLIFERATION AND DEATH AS MEASURED BY INCORPORATION AND ELIMINATION OF IODODEOXYURIDINE. Fed Proc. 1964 May-Jun;23:640–648. [PubMed] [Google Scholar]
  5. Hall J. G., Smith M. E. Homing of lymph-borne immunoblasts to the gut. Nature. 1970 Apr 18;226(5242):262–263. doi: 10.1038/226262a0. [DOI] [PubMed] [Google Scholar]
  6. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages. Proc Soc Exp Biol Med. 1972 Mar;139(3):1049–1052. doi: 10.3181/00379727-139-36295. [DOI] [PubMed] [Google Scholar]
  7. Hofer K. G., Prensky W., Hughes W. L. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer Inst. 1969 Oct;43(4):763–773. [PubMed] [Google Scholar]
  8. Parr I., Wheeler E., Alexander P. Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA. Br J Cancer. 1973 May;27(5):370–389. doi: 10.1038/bjc.1973.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Proctor J., Rudenstam C. M., Alexander P. Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system. Biomedicine. 1973 Jun 20;19(6):248–252. [PubMed] [Google Scholar]
  10. SELECKI E. E. A study of the metastatic distribution of Erlich ascites tumour cells in mice. Aust J Exp Biol Med Sci. 1959 Oct;37:489–498. doi: 10.1038/icb.1959.50. [DOI] [PubMed] [Google Scholar]
  11. SHORTER R. G., BOLLMAN J. L. Experimental transfusion of lymphocytes. Am J Physiol. 1960 May;198:1014–1018. doi: 10.1152/ajplegacy.1960.198.5.1014. [DOI] [PubMed] [Google Scholar]
  12. Stryckmans P. A., Chanana A. D., Cronkite E. P., Greenberg M. L., Schiffer L. M. Studies on lymphocytes. IX. The survival of atuotransfused labeled lymphocytes in chronic lymphocytic leukemia. Eur J Cancer. 1968 May;4(2):241–246. doi: 10.1016/0014-2964(68)90023-6. [DOI] [PubMed] [Google Scholar]
  13. Van Den Brenk H. A., Burch W. M., Kelly H., Orton C. Venous diversion trapping and growth of blood-borne cancer cells en route to the lungs. Br J Cancer. 1975 Jan;31(1):46–61. doi: 10.1038/bjc.1975.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. WANG L. Plasma volume, cell volume, total blood volume and F cells factor in the normal and splenectomized Sherman rat. Am J Physiol. 1959 Jan;196(1):188–192. doi: 10.1152/ajplegacy.1958.196.1.188. [DOI] [PubMed] [Google Scholar]
  15. Weiss L., Glaves D., Waite D. A. The influence of host immunity on the arrest of circulating cancer cells, and its modification by neuraminidase. Int J Cancer. 1974 Jun 15;13(6):850–862. doi: 10.1002/ijc.2910130612. [DOI] [PubMed] [Google Scholar]
  16. Woodruff J. J., Gesner B. M. The effect of neuraminidase on the fate of transfused lymphocytes. J Exp Med. 1969 Mar 1;129(3):551–567. doi: 10.1084/jem.129.3.551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wrathmell A. B. The growth patterns of two transplantable acute leukaemias of spontaneous origin in rats. Br J Cancer. 1976 Feb;33(2):172–180. doi: 10.1038/bjc.1976.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wrathmell A., Alexander P. Growth characteristics and immunological properties of a myeloblastic and a lymphoblastic leukaemia in pure line rats. Bibl Haematol. 1973;39:649–653. doi: 10.1159/000427892. [DOI] [PubMed] [Google Scholar]
  19. van Putten L. M., Kram L. K., van Dierendonck H. H., Smink T., Füzy M. Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection. Int J Cancer. 1975 Apr 15;15(4):588–595. doi: 10.1002/ijc.2910150408. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES